Web Results

en.wikipedia.org/wiki/Abarelix

Abarelix (trade name Plenaxis) is an injectable gonadotropin-releasing hormone antagonist (GnRH antagonist). It is primarily used in oncology to reduce the ...

www.rxlist.com/plenaxis-drug.htm

Apr 3, 2017 ... Learn about Plenaxis (Abarelix) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related ...

www.drugbank.ca/drugs/DB00106

Jun 13, 2005 ... Name, Abarelix. Accession Number, DB00106 (BTD00051, BIOD00051). Type, Biotech. Groups, Approved, Investigational, Withdrawn.

www.drugs.com/cdi/abarelix.html

Easy to read patient leaflet for abarelix. Includes indications, proper use, special instructions, precautions, and possible side effects.

pubchem.ncbi.nlm.nih.gov/compound/Abarelix

Abarelix is a synthetic decapeptide and antagonist of naturally occurring gonadotropin-releasing hormone (GnRH). Abarelix directly and competitively binds to ...

www.drugs.com/mtm/abarelix.html

Abarelix reduces the amount of testosterone produced in the body. Abarelix is used in the palliative treatment of advanced prostate cancer. Abarelix may also be ...

www.drugs.com/monograph/abarelix.html

Abarelix reference guide for safe and effective use from the American Society of Health-System Pharmacists (AHFS DI).

www.centerwatch.com/drug-information/fda-approved-drugs/drug/846/plenaxis-abarelix-for-injectable-suspension

Plenaxis (abarelix for injectable suspension): For treatment of advanced prostate cancer. New approved drug details including side effects, uses and general ...

www.accessdata.fda.gov/drugsatfda_docs/label/2003/21320_plenaxis_lbl.pdf

Abarelix for injectable suspension (Plenaxis™) is a synthetic decapeptide with potent ... The molecular weight for abarelix anhydrous free base is 1416.06.